title: Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial.
abstract: There has been a recent shift from a uniform treatment targeting HbA1c to a patient centered approach due to disappointing results of intensified glucose control in mega-trials such as VADT, ADVANCE, and ACCORD. In addition, morbidity and mortality has been substantially reduced since the UKPDS leading to an overestimation of the absolute risk for cardiovascular complications in randomized controlled trials. With substantial progress in prevention of cardiovascular complications, patients with type 2 diabetes now survive long enough to face diabetes-related complications and cancer risk. This requires rethinking of antidiabetic treatment strategies as exemplified by a recent consensus statement of the EASD and ADA, calling for a more patient centered treatment. Within this context the value of early insulin initiation was reinforced, the clinical utility of which has been demonstrated in the recent ORIGIN trial. ORIGIN demonstrated neutral results for the primary endpoint, but reduced microangiopathy in patients with an HbA1c value of ≥6.4 % with basal insulin glargine. After 5 years of follow-up 77 % of the patients in the glargine arm and 66 % with standard care remained at an HbA1c <7 %. An ongoing long-term follow-up (ORIGINALE) will clarify whether this also translates into a reduction of macrovascular events and mortality.
authors: GWT-TUD mbH, Study Center Professor Hanefeld, Fiedlerstr. 34, 01307 Dresden, Germany. hanefeld@gwtonline-zks.de
authors: Markolf
authors: M
authors: Hanefeld
authors: Peter
authors: P
authors: Bramlage
mesh_terms: D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D018802:Patient-Centered Care; D016032:Randomized Controlled Trials as Topic
chemical_list: D007328:Insulin; D005947:Glucose
references: Diabetes Metab Res Rev. 2005 Jan-Feb;21(1):31-8
references: 15624123
references: N Engl J Med. 2011 Mar 3;364(9):818-28
references: 21366473
references: Exp Clin Endocrinol Diabetes. 2009 Jan;117(1):6-14
references: 18465681
references: Diabetologia. 2010 Jul;53(7):1258-69
references: 20352408
references: N Engl J Med. 2006 Dec 7;355(23):2427-43
references: 17145742
references: Diabetes Obes Metab. 2011 Sep;13(9):814-22
references: 21481127
references: N Engl J Med. 2012 Nov;367(18):1762-3; author reply 1763-4
references: 23113496
references: Endocrinology. 2008 Feb;149(2):717-24
references: 17962340
references: Diabetes Care. 2004 Nov;27(11):2597-602
references: 15504992
references: Discov Med. 2011 Mar;11(58):255-63
references: 21447284
references: N Engl J Med. 2009 Jan 8;360(2):129-39
references: 19092145
references: Exp Clin Endocrinol Diabetes. 2009 Oct;117(9):522-57
references: 19876795
references: N Engl J Med. 2005 Dec 22;353(25):2643-53
references: 16371630
references: N Engl J Med. 2010 Oct 7;363(15):1410-8
references: 20925543
references: Ann Intern Med. 1999 Aug 17;131(4):281-303
references: 10454950
references: Korean J Intern Med. 2010 Sep;25(3):273-81
references: 20830224
references: J Clin Invest. 1989 Jul;84(1):205-13
references: 2661589
references: Diabetes Res Clin Pract. 2014 Apr;104(1):1-52
references: 24508150
references: Lancet. 1998 Sep 12;352(9131):837-53
references: 9742976
references: Lancet. 2005 Oct 8;366(9493):1279-89
references: 16214598
references: Endocr Rev. 2008 May;29(3):351-66
references: 18048763
references: Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23
references: 18391651
references: Dtsch Med Wochenschr. 2009 Feb;134(7):291-7
references: 19197810
references: Diabet Med. 2010 Feb;27(2):175-80
references: 20546261
references: N Engl J Med. 2003 Jan 30;348(5):383-93
references: 12556541
references: N Engl J Med. 2012 Jul 26;367(4):319-28
references: 22686416
references: Chin Med J (Engl). 2009 Nov 5;122(21):2554-9
references: 19951569
references: Lancet. 1998 Sep 12;352(9131):854-65
references: 9742977
references: Diabet Med. 2009 Dec;26(12):1185-92
references: 20002468
references: Diabetologia. 2011 Jun;54(6):1308-17
references: 21359582
references: Lancet. 2009 May 23;373(9677):1765-72
references: 19465231
references: Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E997-1002
references: 11052953
references: Diabetes Care. 2012 Jun;35(6):1364-79
references: 22517736
references: Diabetes. 2001 Sep;50(9):2001-12
references: 11522665
references: Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S2-6
references: 20115927
references: Cardiovasc Diabetol. 2010 Sep 16;9:53
references: 20843379
references: Diabetologia. 2009 Sep;52(9):1732-44
references: 19565214
references: N Engl J Med. 2008 Feb 7;358(6):580-91
references: 18256393
references: BMC Endocr Disord. 2012 Oct 17;12:23
references: 23075070
references: N Engl J Med. 2008 Oct 9;359(15):1577-89
references: 18784090
references: Can Fam Physician. 2009 Jan;55(1):39-43
references: 19155364
references: N Engl J Med. 2008 Jun 12;358(24):2560-72
references: 18539916
references: Diabetologia. 2012 Jan;55(1):51-62
references: 21956710
references: Diabetes Care. 2011 Sep;34(9):2048-53
references: 21775756
references: Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
references: 22187469
references: Diabetes Care. 2012 Sep;35(9):1897-901
references: 22699297